CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AMGN

Anvumetostat

Phase 2
Amgen Inc. (AMGN)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Nov '26
AMGNPhase 2

Anvumetostat Phase 2 Est. Readout

Anvumetostat
Nov 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Advanced MTAP-null Solid Tumors

View Full Landscape
Drug Information

Target Indication

Advanced MTAP-null Solid Tumors

Clinical Trial

NCT05094336

Last updated: 9/18/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.